Analysis of the Pharmaceutical Market in Malaysia

Analysis of the Pharmaceutical Market in Malaysia

Attractiveness and Hurdles for Stakeholders in the Next 5 Years

RELEASE DATE
16-Jun-2015
REGION
North America
Research Code: 9AB9-00-22-00-00
SKU: LS00071-NA-MR_16912
$1,500.00
In stock
SKU
LS00071-NA-MR_16912
$1,500.00
Links

Pay by invoice

ENQUIRE NOW

Description

The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.

Table of Contents

Key Findings

Key Questions this Study will Answer

Overview of the Malaysian Healthcare Market

Overview of the Malaysian Healthcare Market (continued)

Overview of the Malaysian Healthcare Market (continued)

Overview of the Malaysian Healthcare Market (continued)

Overview of the Malaysian Healthcare Market (continued)

Overview of the Malaysian Healthcare Market (continued)

Overview of the Malaysian Healthcare Market (continued)

Overview of Malaysian Public and Private Healthcare Systems

Overview of Malaysian Public and Private Healthcare Systems (continued)

Algorithm of Malaysian Healthcare Systems

Algorithm of Private Healthcare Systems

Future Roadblocks

Distribution of Household Income Up to 2012

Key Driver in the Malaysian Hospital Market—Growing Admission of Elderly Population

Key Driver in the Malaysian Private Hospital Segment—Medical Tourism

Key Drivers in the Malaysian Hospital Market—Chronic and Lifestyle Diseases

Overview of the Malaysian Pharmaceutical Market

Revenue Forecast for the Malaysian Pharmaceutical Market

Pharmaceutical Market Components by Percentage

Malaysian Pharmaceutical Market—Segmentation

Malaysian Pharmaceutical Market—Segmentation (continued)

Halal Medicine Market in Malaysia

Malaysian Regulatory Landscape

Key Driver in the Malaysian Pharmaceutical Market—NKEA

Impact of GST on Malaysian Pharmaceutical Market

Home-grown Participants in the Malaysian Pharmaceutical Market

CCM Pharmaceuticals Sdn Bhd

Kotra Pharma (M) Sdn Bhd

Pharmaniaga Berhad

YSP Industries (M) Sdn Bhd

Hovid Berhad

MNC Participants in the Malaysian Pharmaceutical Market

Pfizer Malaysia

Merck Sharp & Dohme (MSD)

Eli Lilly

GlaxoSmithKline (GSK)

Johnson & Johnson Sdn Bhd

PESTLE Analysis

Porter Five Forces Analysis for the Malaysian Pharmaceutical Market

The Future of the Malaysian Pharmaceutical Market—Key Focus Areas

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research

2016-17 Outlook for Indian Agriculture and Rural Demand

Release Date: 18-May-16
Region: Global

Monthly CPI & WPI Inflation, April 2016

Release Date: 18-May-16
Region: Global

India Investment Tracker January–March 2016

Release Date: 18-May-16
Region: South Asia, Middle East & North Africa

Country Profile – Russia

Release Date: 13-May-16
Region: Asia Pacific

North American Protein Ingredients Market, Forecast to 2020

Release Date: 13-May-16
Region: North America

Global Economic Tracker—Insights and Trends (GET-IT)—Emerging Middle East and Africa Q2 2016

Release Date: 12-May-16
Region: South Asia, Middle East & North Africa

Middle East and North Africa Investment Tracker January-March 2016

Release Date: 11-May-16
Region: South Asia, Middle East & North Africa

Asia-Pacific Telehealth Market Outlook, Forecast to 2020

Release Date: 11-May-16
Region: Asia Pacific

Digital Transformation in the Global Food & Agriculture Market

Release Date: 9-May-2016
Region: North America
This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segmentsgene therapy, tissue engineering, and small molecules and biologicshas also been provided.
More Information
No Index No
Podcast No
Lightbox Content World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019
Author Rageshwary Ramupillai
WIP Number 9AB9-00-22-00-00
Is Prebook No